These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6439386)

  • 1. Systemic treatment of septicaemia caused by P. aeruginosa with special reference to azlocillin.
    Shah PM
    Burns Incl Therm Inj; 1984 Oct; 11(1):65-71. PubMed ID: 6439386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fosfomycin, piperacillin, azlocillin. Correlation between therapeutic response of mice infected with Pseudomonas aeruginosa and in vitro data.
    Haag R
    Chemotherapy; 1984; 30(4):227-36. PubMed ID: 6430654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of ciprofloxacin, azlocillin, and tobramycin alone and in combination in experimental Pseudomonas sepsis.
    Johnson M; Miniter P; Andriole VT
    J Infect Dis; 1987 Apr; 155(4):783-8. PubMed ID: 3102631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monotherapy of Pseudomonas aeruginosa septicemia with azlocillin].
    Godard J; Aubertin J; Borderon JC; Dureux JB; Motin J
    Presse Med; 1984 Mar; 13(13):819-21. PubMed ID: 6231603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibiotic treatment of chronic Pseudomonas aeruginosa infection in cystic fibrosis patients.
    Møller NE; Høiby N
    Scand J Infect Dis Suppl; 1981; 29():87-91. PubMed ID: 6458884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of in vitro synergy between several beta-lactam and aminoglycoside antibiotics against endocarditis strains of Pseudomonas aeruginosa.
    Reyes MP; Smith F; Lerner AM
    J Infect; 1984 Mar; 8(2):110-7. PubMed ID: 6725964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azlocillin in the treatment of serious infection with Pseudomonas aeruginosa.
    Eykyn SJ
    J Antimicrob Chemother; 1982 May; 9(5):395-403. PubMed ID: 6807951
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of single-agent therapy with azlocillin, ticarcillin, and amikacin and beta-lactam/amikacin combinations for treatment of Pseudomonas aeruginosa bacteremia in granulocytopenic rats.
    Johnson DE; Thompson B
    Am J Med; 1986 May; 80(5C):53-8. PubMed ID: 3636060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy against Pseudomonas aeruginosa in cystic fibrosis. A study of carbenicillin, azlocillin or piperacillin in combination with tobramycin.
    Møller NE; Eriksen KR; Feddersen C; Flensborg EW; Høiby N; Norn S; Rosendal K; Schiøtz PO; Skov PS
    Eur J Respir Dis; 1982 Mar; 63(2):130-9. PubMed ID: 6461561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Evaluation of the clinical activity of azlocillin. A multicenter study conducted in 14 centers].
    Konopka CA
    Presse Med; 1984 Mar; 13(13):808-11. PubMed ID: 6231600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.
    Follath F; Bindschedler M; Wenk M; Frei R; Stalder H; Reber H
    Eur J Clin Microbiol; 1986 Apr; 5(2):236-40. PubMed ID: 2941289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro evaluation of newer beta-lactam antibiotics against gram negative bacilli isolated from neutropenic patients.
    Ebenezer S; Lalitha MK; Jesudason MV; Chandy M
    Indian J Cancer; 1994 Mar; 31(1):23-6. PubMed ID: 8063332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergy of ciprofloxacin and azlocillin in vitro and in a neutropenic mouse model of infection.
    Chin NX; Jules K; Neu HC
    Eur J Clin Microbiol; 1986 Feb; 5(1):23-8. PubMed ID: 2938945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pseudomonas aeruginosa bacteriaemia: new clinical and therapeutic aspects ].
    Janbon F; Despaux E; Lepeu G; Jonquet O; Santoni A; Balmayer B; Bertrand A
    Pathol Biol (Paris); 1982 Jun; 30(6 Pt 2):563-7. PubMed ID: 6812007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combinations of antibiotics against Pseudomonas aeruginosa.
    Baltch AL; Smith RP
    Am J Med; 1985 Jul; 79(1A):8-16. PubMed ID: 3927722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of ciprofloxacin alone and in combination with azlocillin in experimental endocarditis due to Pseudomonas aeruginosa.
    Thauvin C; Lecomte F; Le Boete I; Grise G; Lemeland JF
    Infection; 1989; 17(1):31-4. PubMed ID: 2493429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo efficacy of azlocillin and amikacin versus ciprofloxacin with and without amikacin in experimental right-sided endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Kim KS
    Chemotherapy; 1986; 32(4):364-73. PubMed ID: 2942342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergy of azlocillin with aminoglycosides.
    Chin NX; Neu HC
    J Antimicrob Chemother; 1983 May; 11 Suppl B():33-8. PubMed ID: 6413482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of ciprofloxacin, azlocillin, imipenem/cilastatin and tobramycin in a model of experimental septicemia due to Pseudomonas aeruginosa in neutropenic mice.
    Ulrich E; Trautmann M; Krause B; Bauernfeind A; Hahn H
    Infection; 1989; 17(5):311-5. PubMed ID: 2599653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ciprofloxacin in experimental aortic valve endocarditis due to Pseudomonas aeruginosa.
    Bayer AS; Blomquist IK; Kim KS
    J Antimicrob Chemother; 1986 May; 17(5):641-9. PubMed ID: 2941403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.